No. The 2025 BIO CEO & Investor Conference will be held in person February 10-11 at the New York Marriott Marquis.
Will the BIO CEO & Investor Conference offer a virtual option?
Is there a government/academic discount?
How do I pay by wire transfer?
What are your Cancellation & Substitution Policies?
How do I make a correction or change to my registration?
Yes, BIO members receive reduced rates at all BIO events. To learn more about member benefits and to join, please click here.
What if I become a member of BIO after I have registered as a non-member?
You should contact the team at CustomerCare@bio.org, and after verification from the BIO Membership department, the proper adjustment will be made to your record and a credit card refund will be issued.
I am a service provider. How should I participate?
For service providers to access BIO One-on-One Partnering, the organization must sponsor at a specific level. Our Sales and Sponsorship team is always ready to support your event engagement. Please feel free to reach out to the team at +1.202.312.9264 or sponsor@bio.org.
Is media registration complimentary?
Media registration is open to editors and reporters working full-time for print, broadcast, or web publications with valid press credentials. Please contact tbrady@bio.org for more information.
How do I change my email address?
Corrections to your email address should be emailed to CustomerCare@bio.org, please allow up to 4 business days for a new confirmation to be sent.
Why have I not received a registration confirmation?
All confirmations are HTML (Web) pages at the conclusion of your registration and are printable. Additionally, an email confirmation is sent immediately following the completion of online registration, sent from our registration provider, Maritz. If you have not received a confirmation, please check your spam or junk mail folder.
How do I get my registration confirmation to be resent to me?
Whom should I contact if I have questions?
The BIO CEO & Investor Conference will feature presentations primarily by early and established private companies, as well as some emerging public companies. Those interested in presenting must have a clear R&D focus, with a pipeline involving biotechnology therapeutics, diagnostics, or platform technologies. This can include patient advocacy groups. All applications submitted will be reviewed and appropriate companies will be approved to present.
Service providers will not be considered, but should email our Sponsorship Team to discuss alternative ways to highlight your initiatives with a dedicated team member.
Yes. Presentation fees are different depending on company type. Please refer to the Company Type chart here.